tretazicar has been researched along with Colorectal Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doshi, R; Green, NK; Kerr, DJ; McNeish, IA; Searle, PF; Young, LS | 1 |
| Bonney, S; Ellis, J; Gerritsen, W; Harris, PA; Hill, S; Horne, M; Hubscher, S; Hull, D; James, ND; Kerr, DJ; Mautner, V; Mirza, D; Mountain, A; Oliff, S; Palmer, DH; Rajaratnam, R; Reynolds, G; Searle, PF; van der Sijp, JR; Young, LS | 1 |
| Chen, MJ; Flavell, JR; Green, NK; Kerr, DJ; Mautner, V; Reynolds, GM; Searle, PF; Young, LS | 1 |
| Anlezark, G; Anné, J; Burke, PJ; Dubois, L; Dûrre, P; Lambin, P; Landuyt, W; Mengesha, A; Minton, NP; Pennington, O; Theys, J; Vaughan, T; Wouters, BG | 1 |
| Djeha, AH; Harris, PA; Kerr, DJ; Leung, H; Mountain, A; Searle, PF; Thomson, TA; Wrighton, CJ; Young, LS | 1 |
| Chen, MJ; Chung-Faye, GA; Kerr, DJ; Searle, PF; Young, LS | 1 |
| Djeha, AH; Ismail, T; Lipinski, KS; Mountain, A; Wrighton, CJ; Young, LS | 1 |
1 review(s) available for tretazicar and Colorectal Cancer
| Article | Year |
|---|---|
Gene therapy for colorectal cancer: therapeutic potential.
Topics: Adenoviridae; Antigen Presentation; Aziridines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Flucytosine; Ganciclovir; Genes, p53; Genetic Therapy; Humans; T-Lymphocytes, Cytotoxic | 2001 |
1 trial(s) available for tretazicar and Colorectal Cancer
| Article | Year |
|---|---|
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
Topics: Adenoviridae; Aged; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; DNA Adducts; Drug Resistance, Neoplasm; Escherichia coli Proteins; Female; Flavoproteins; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Half-Life; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Nitroreductases; Prodrugs; Transgenes; Virus Replication | 2004 |
5 other study(ies) available for tretazicar and Colorectal Cancer
| Article | Year |
|---|---|
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.
Topics: Adenocarcinoma; Adenoviruses, Human; Adjuvants, Immunologic; Animals; Antineoplastic Agents, Alkylating; Aziridines; Bystander Effect; Colorectal Neoplasms; Combined Modality Therapy; Cytomegalovirus; Defective Viruses; Drug Resistance, Neoplasm; Escherichia coli Proteins; Female; Genes; Genes, Synthetic; Genetic Therapy; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Mesothelioma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroreductases; Prodrugs; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2003 |
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.
Topics: Adenoviridae; Adenovirus E2 Proteins; Animals; Aziridines; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Activation; Escherichia coli; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Nude; Nitroreductases; Prodrugs; Virus Replication | 2004 |
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Line; Cell Survival; Clostridium; Colorectal Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Genetic Therapy; Genetic Vectors; HCT116 Cells; Humans; Mice; Mice, Inbred Strains; Mice, Nude; Nitroreductases; Prodrugs; Recombinant Proteins; Spores, Bacterial; Treatment Outcome; Xenograft Model Antitumor Assays | 2006 |
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Drug; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Head and Neck Neoplasms; Humans; Liver Neoplasms; Luciferases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; beta Catenin; beta-Galactosidase; Biopsy; Colorectal Neoplasms; Cytoskeletal Proteins; Gene Expression Regulation, Neoplastic; Genes, Reporter; Genetic Therapy; Genetic Vectors; Humans; Liver; Mice; Nitroreductases; Organ Specificity; Prodrugs; Promoter Regions, Genetic; Trans-Activators; Transgenes; Tumor Cells, Cultured | 2001 |